dreamproit/uscode huggingface dataset:
42 U.S.C. § 19114 (THE PUBLIC HEALTH AND WELFARE)
§ 19114. Research and development awards
(a) In general
From amounts made available for the Directorate, the Director shall make awards, on a competitive basis, for research and technology development within the key technology focus areas, including investments that advance solutions to the challenges under section 19107 of this title.
(b) Purpose
The purpose of the awards under this section shall be to accelerate technological advances and technology adoption in the key technology focus areas.
(c) Recipients
Recipients of funds under this section may include institutions of higher education, research institutions, non-profit organizations, private sector entities, consortia, or other entities as defined by the Director.
(d) Metrics
The Director may set metrics, including goals and deadlines, for the development and demonstration of technology as determined in the terms of the award, and may use such metrics to determine whether an award recipient shall be eligible for continued or follow-on funding.
(e) Short term technology deployment
The Director shall also make awards, including through the SBIR and STTR programs (as defined in section 638(e) of title 15), to expedite short-term technology deployment within a period of no longer than 24 months.
(f) Selection criteria
In selecting recipients for an award under this section, the Director shall consider, at a minimum—
(1) the relevance of the project to the challenges and the key technology focus areas under section 19107 of this title, and the potential of the project to result in transformational advances for such challenges and the key technology focus areas;
(2) the current status of similar technology, the limits of current practice, and the novelty and risks of the proposed project;
(3) the ethical, societal, safety, and security implications relevant to the application of the technology;
(4) the appropriateness of quantitative goals and metrics for evaluating the project and a plan for evaluating those metrics; and
(5) the path for developing and, as appropriate, commercializing the technology into products and processes in the United States.
(g) Authorization of appropriations
From within funds authorized for the Directorate for Technology, Innovation, and Partnerships, there are authorized to carry out the activities under this section $1,000,000,000 for fiscal years 2023 through 2027.
(Pub. L. 117–167, div. B, title III, § 10394, Aug. 9, 2022, 136 Stat. 1591.)
42 U.S.C. § 19117 (THE PUBLIC HEALTH AND WELFARE)
§ 19117. Coordination of activities
(a) In general
In carrying out the activities of the Directorate, the Director shall coordinate and collaborate as appropriate with the Secretary of Energy, the Director of the National Institute of Standards and Technology, and the heads of other Federal research agencies, as appropriate, to further the goals of this part.
(b) Avoid duplication
The Director shall ensure, to the greatest extent practicable, that activities carried out by the Directorate are not duplicative of activities supported by other parts of the Foundation or other relevant Federal agencies. In carrying out the activities prescribed by this division, the Director shall coordinate with the interagency working group established under part D of subchapter VI and heads of other Federal research agencies to ensure these activities enhance and complement, but do not constitute unnecessary duplication of effort and to ensure the responsible stewardship of funds.
(c) Emerging technologies
After completion of the studies regarding emerging technologies conducted by the Secretary of Commerce under title XV of division FF of the Consolidated Appropriations Act, 2021 (Public Law 116–260), the Director shall consider the results of such studies in carrying out the activities of the Directorate.
(Pub. L. 117–167, div. B, title III, § 10397, Aug. 9, 2022, 136 Stat. 1597.)
heading: Editorial Notes
heading: References in Text
text: This division, referred to in subsec. (b), is div. B of Pub. L. 117–167, Aug. 9, 2022, 136 Stat. 1399, which enacted this chapter and enacted, amended, and repealed numerous other sections and notes in the Code. For complete classification of div. B to the Code, see Short Title note set out under section 18901 of this title and Tables.
Title XV of division FF of the Consolidated Appropriations Act, 2021, referred to in subsec. (c), is title XV of Pub. L. 116–260, div. FF, Dec. 27, 2020, 134 Stat. 3276, known as the American Competitiveness Of a More Productive Emerging Tech Economy Act, and also known as the American COMPETE Act, which is not classified to the Code.
42 U.S.C. § 19118 (THE PUBLIC HEALTH AND WELFARE)
§ 19118. Ethical, legal, and societal considerations
The Director shall engage, as appropriate, experts in the social dimensions of science and technology and set up formal avenues for public input, as appropriate, to ensure that ethical, legal, and societal considerations are taken into account in the priorities and activities of the Directorate, including in the selection of the challenges and key technology focus areas under section 19107 of this title and the award-making process, and throughout all stages of supported projects.
(Pub. L. 117–167, div. B, title III, § 10398, Aug. 9, 2022, 136 Stat. 1597.)
42 U.S.C. § 19119 (THE PUBLIC HEALTH AND WELFARE)
§ 19119. Reports and roadmaps
(a) Annual report
The Director shall provide to the relevant authorizing and appropriations committees of Congress an annual report describing projects supported by the Directorate during the previous year.
(b) Roadmap
Not later than 1 year after August 9, 2022, the Director shall provide to the relevant authorizing and appropriations committees of Congress a roadmap describing the strategic vision that the Directorate will use to guide investment decisions over the following 3 years.
(c) Reports
Not later than 1 year after August 9, 2022, and every 3 years thereafter, the Director, in consultation with the heads of relevant Federal agencies, shall prepare and submit to Congress—
(1) a strategic vision for the next 5 years for the Directorate, including a description of how the Foundation will increase funding for research and education for populations underrepresented in STEM and geographic areas; and
(2) a description of the planned activities of the Directorate to secure federally funded science and technology pursuant to section 1746 of the National Defense Authorization Act for Fiscal Year 2020 (Public Law 116–92; 42 U.S.C. 6601 note) and section 6605 of this title and the requirements under part D of this subchapter and subtitle E of title VI.
(d) Selection criteria report
Not later than 24 months after the establishment of the Directorate, the Director shall prepare and submit a report to Congress regarding the use of alternative methods for the selection of award recipients and the distribution of funding to recipients, as compared to the traditional peer review process.
(Pub. L. 117–167, div. B, title III, § 10399, Aug. 9, 2022, 136 Stat. 1598.)
heading: Editorial Notes
heading: References in Text
text: Subtitle E of title VI, referred to in subsec. (c)(2), is subtitle E (§§ 10641–10649) of title VI of div. B of Pub. L. 117–167, Aug. 9, 2022, 136 Stat. 1672, known as the Coastal and Ocean Acidification Research and Innovation Act of 2021. For complete classification of subtitle E to the Code, see Short Title of 2022 Amendment note set out under section 3701 of Title 33, Navigation and Navigable Waters, and Tables.
42 U.S.C. § 19120 (THE PUBLIC HEALTH AND WELFARE)
§ 19120. Evaluation
(a) In general
After the Directorate has been in operation for 6 years, the Director shall enter into an agreement with the National Academies to provide an evaluation of how well the Directorate is achieving the purposes identified in section 19102 of this title.
(b) Inclusions
The evaluation shall include—
(1) an assessment of the impact of Directorate activities on the Foundation’s primary science mission;
(2) an assessment of the Directorate’s impact on the challenges and key technology focus areas under section 19107 of this title;
(3) an assessment of efforts to ensure coordination between the Directorate and other Federal agencies, and with external entities;
(4) a description of lessons learned from operation of the Directorate; and
(5) recommended funding levels for the Directorate;
(c) Availability
On completion of the evaluation, the evaluation shall be made available to Congress and the public.
(Pub. L. 117–167, div. B, title III, § 10399A, Aug. 9, 2022, 136 Stat. 1598.)
42 U.S.C. § 19131 (THE PUBLIC HEALTH AND WELFARE)
§ 19131. Definitions
In this subchapter:
(1) Initiative
The term “Initiative” means the National Engineering Biology Research and Development Initiative established under section 19132 of this title.
(2) Omics
The term “omics” refers to the collective technologies used to explore the roles, relationships, and actions of the various types of molecules that make up the cells and systems of an organism and the systems level analysis of their functions.
(Pub. L. 117–167, div. B, title IV, § 10401, Aug. 9, 2022, 136 Stat. 1599.)
42 U.S.C. § 19134 (THE PUBLIC HEALTH AND WELFARE)
§ 19134. Advisory committee on engineering biology research and development
(a) In general
The agency co-chair of the interagency committee established under section 19133 of this title shall, in consultation with the Office of Science and Technology Policy, designate or establish an advisory committee on engineering biology research and development (in this section referred to as the “advisory committee”) to be composed of not fewer than 12 members, including representatives of research and academic institutions, industry, and nongovernmental entities, who are qualified to provide advice on the Initiative.
(b) Assessment
The advisory committee shall assess the following:
(1) The current state of United States competitiveness in engineering biology, including the scope and scale of United States investments in engineering biology research and development in the international context.
(2) Current market barriers to commercialization of engineering biology products, processes, and tools in the United States.
(3) Progress made in implementing the Initiative.
(4) The need to revise the Initiative.
(5) The balance of activities and funding across the Initiative.
(6) Whether the strategic plan developed or updated by the interagency committee established under section 19133 of this title is helping to maintain United States leadership in engineering biology.
(7) Whether ethical, legal, environmental, safety, security, and other appropriate societal issues are adequately addressed by the Initiative.
(c) Reports
Beginning not later than two years after August 9, 2022, and not less frequently than once every five years thereafter, the advisory committee shall submit to the President, the Committee on Science, Space, and Technology, the Committee on Energy and Commerce, and the Committee on Agriculture of the House of Representatives, and the Committee on Commerce, Science, and Transportation, the Committee on Health, Education, Labor, and Pensions, and the Committee on Agriculture, Nutrition, and Forestry of the Senate, a report on the following:
(1) The findings of the advisory committee’s assessment under subsection (b).
(2) The advisory committee’s recommendations for ways to improve the Initiative.
(d) Application of Federal Advisory Committee Act
Section 14 of the Federal Advisory Committee Act (5 U.S.C. App.) shall not apply to the advisory committee.
(e) Termination
The advisory committee established under subsection (a) shall terminate on the date that is 10 years after August 9, 2022.
(Pub. L. 117–167, div. B, title IV, § 10404, Aug. 9, 2022, 136 Stat. 1605.)
heading: Editorial Notes
heading: References in Text
text: Section 14 of the Federal Advisory Committee Act, referred to in subsec. (d), is section 14 of Pub. L. 92–463, which is set out in the Appendix to Title 5, Government Organization and Employees.
42 U.S.C. § 19136 (THE PUBLIC HEALTH AND WELFARE)
§ 19136. Rule of construction
Nothing in this subchapter may be construed to require public disclosure of information that is exempt from mandatory disclosure under section 552 of title 5.
(Pub. L. 117–167, div. B, title IV, § 10407, Aug. 9, 2022, 136 Stat. 1609.)
42 U.S.C. § 19151 (THE PUBLIC HEALTH AND WELFARE)
§ 19151. Federal research agency policies for caregivers
(a) OSTP guidance
Not later than 12 months after August 9, 2022, the Director, in consultation with the heads of relevant agencies, shall provide guidance to each Federal research agency to establish policies that—
(1) apply to all—
(A) research awards granted by such agency; and
(B) principal investigators of such research and their trainees, including postdoctoral researchers and graduate students, who have caregiving responsibilities, including care for a newborn or newly adopted child and care for an immediate family member who has a disability or a serious health condition; and
(2) provide, to the extent feasible—
(A) flexibility in timing for the initiation of approved research awards granted by such agency;
(B) no-cost extensions of such research awards;
(C) award supplements, as appropriate, to research awards to sustain research activities conducted under such awards; and
(D) any other appropriate accommodations at the discretion of the director of each such agency.
(b) Uniformity of guidance
In providing guidance under subsection (a), the Director shall encourage uniformity, to the extent practicable, and consistency in the policies established pursuant to such guidance across all Federal research agencies.
(c) Establishment of policies
Consistent, to the extent practicable, with the guidance under subsection (a), Federal research agencies shall—
(1) maintain or develop and implement policies for individuals described in paragraph (1)(B) of such subsection; and
(2) broadly disseminate in easily accessible formats such policies to current and potential award recipients.
(d) Data on usage
Federal research agencies shall consider—
(1) collecting data, including demographic data that can be disaggregated by sex, geographic location, and socioeconomic indicators, which may include employment status, occupation, educational attainment, parental education, and income, on the usage of the policies under subsection (c), at both institutions of higher education and Federal laboratories; and
(2) reporting such data on an annual basis to the Director in such form as required by the Director.
(Pub. L. 117–167, div. B, title V, § 10501, Aug. 9, 2022, 136 Stat. 1609.)
42 U.S.C. § 19152 (THE PUBLIC HEALTH AND WELFARE)
§ 19152. Collection and reporting of data on Federal research awards
(a) Collection of data
(1) In general
Each Federal research agency shall collect, as practicable, with respect to all applications for merit-reviewed research and development awards made by such agency, standardized record-level annual information on demographics, primary field, award type, institution type, review rating, budget request, funding outcome, and awarded budget.
(2) Uniformity and standardization
The Director, in consultation with the heads of each Federal research agency, shall establish, and update as necessary, a policy to ensure uniformity and standardization of the data collection required under paragraph (1).
(3) Record-level data
(A) Requirement
Beginning not later than two years after the issuance of the policy under paragraph (2) to Federal research agencies, and on an annual basis thereafter, each Federal research agency shall submit to the National Center for Science and Engineering Statistics record-level data collected under paragraph (1) in the form required by the Director of the National Science Foundation.
(B) Previous data
As part of the first submission under subparagraph (A), each Federal research agency, to the extent practicable, shall also submit comparable record-level data, if it is available to the agency, for the five years preceding the date of such submission, or an analysis for why such data cannot be provided.
(b) Reporting of data
The Director of the National Science Foundation shall publish statistical summary data, as practicable, collected under this section, disaggregated and cross-tabulated by race, ethnicity, sex, socioeconomic indicators, which may include employment status, occupation, educational attainment, parental education, and income, geographic location, and years since completion of doctoral degree, including in conjunction with the National Science Foundation’s report required by section 1885d of this title.
(Pub. L. 117–167, div. B, title V, § 10502, Aug. 9, 2022, 136 Stat. 1610.)
42 U.S.C. § 19153 (THE PUBLIC HEALTH AND WELFARE)
§ 19153. Policies for review of Federal research awards
(a) Assessment of policies
Federal research agencies shall regularly assess, and update as necessary, policies, and practices to remove or reduce cultural and institutional barriers limiting the recruitment, retention, and success of groups historically underrepresented in STEM research careers, including policies and practices relevant to the unbiased review of Federal research applications.
(b) Considerations and activities
In carrying out the requirements under subsection (a), Federal research agencies shall—
(1) review current levels of participation of groups historically underrepresented in STEM in peer-review panels and consider approaches for expanding their participation;
(2) analyze the data collected under section 19152 of this title, including funding rates of proposals from all groups, including those historically underrepresented in STEM;
(3) collect and disseminate best practices to remove or reduce cultural and institutional barriers limiting the recruitment, retention, and success of groups historically underrepresented in STEM research careers; and
(4) implement evidence-based policies and practices to achieve the goals of this section.
(Pub. L. 117–167, div. B, title V, § 10503, Aug. 9, 2022, 136 Stat. 1610.)
42 U.S.C. § 19154 (THE PUBLIC HEALTH AND WELFARE)
§ 19154. Collection of data on demographics of faculty
(a) Collection of data
(1) In general
Not later than 5 years after August 9, 2022, and at least every five years thereafter, the Director of the National Science Foundation shall carry out a survey to collect data from award recipients on the demographics of STEM faculty, by broad fields of STEM, at different types of institutions of higher education that receive Federal research funding.
(2) Survey considerations
To the extent practicable, the Director of the National Science Foundation shall survey, by sex, race, socioeconomic indicators, which may include employment status, occupation, educational attainment, parental education, and income, geographic location, ethnicity, citizenship status, and years since completion of doctoral degree—
(A) the number and percentage of faculty;
(B) the number and percentage of faculty at each rank;
(C) the number and percentage of faculty who are in nontenure-track positions, including teaching and research;
(D) the number and percentage of faculty who are reviewed for promotion, including tenure, and the percentage of that number who are promoted, including being awarded tenure;
(E) faculty years in rank;
(F) the number and percentage of faculty to leave tenure-track positions;
(G) the number and percentage of faculty hired, by rank; and
(H) the number and percentage of faculty in leadership positions.
(b) Existing surveys
The Director of the National Science Foundation, may, in modifying or expanding existing Federal surveys of higher education (as necessary)—
(1) take into account the considerations under subsection (a)(2) by collaborating with statistical centers at other Federal agencies; or
(2) make an award to an institution of higher education or nonprofit organization (or consortia thereof) to take such considerations into account.
(c) Reporting data
The Director of the National Science Foundation shall publish statistical summary data collected under this section, including as part of the National Science Foundation’s report required by section 1885d of this title.
(d) Authorization of appropriations
There are authorized to be appropriated to the Director of the National Science Foundation $4,000,000 in each of fiscal years 2023 through 2025 to develop and carry out the initial survey required under subsection (a).
(Pub. L. 117–167, div. B, title V, § 10504, Aug. 9, 2022, 136 Stat. 1611.)
42 U.S.C. § 19155 (THE PUBLIC HEALTH AND WELFARE)
§ 19155. Cultural and institutional barriers to expanding the academic and Federal STEM workforce
(a) Best practices
(1) Development of guidance
Not later than 12 months after August 9, 2022, the Director, in consultation with the interagency working group on inclusion in STEM and utilizing existing guidance already developed by Federal research agencies where applicable, shall broadly disseminate to entities that receive Federal research funding best practices for—
(A) conducting periodic climate surveys of STEM departments and divisions, with a particular focus on identifying and addressing any cultural or institutional barriers to the recruitment, retention, or advancement of groups historically underrepresented in STEM studies and careers; and
(B) providing educational opportunities, including workshops, for STEM professionals to learn about current research on effective practices for unbiased recruitment, evaluation, and promotion of undergraduate and graduate students and research personnel.
(2) Establishment of policies
Consistent with the guidance developed under paragraph (1)—
(A) The Director of the National Science Foundation, in consultation with the heads of Federal research agencies, shall develop a policy that—
(i) applies to, at a minimum, doctoral degree granting institutions that receive Federal research funding; and
(ii) requires each such institution, not later than 3 years after August 9, 2022, and to the extent practicable, to report to the Director of the National Science Foundation on activities and policies developed and implemented based on the guidance disseminated under paragraph (1); and
(B) each Federal research agency with a Federal laboratory shall maintain or develop and implement practices and policies for the purposes described in paragraph (1) for such laboratory and, not later than three years after August 9, 2022, each Federal laboratory shall report to the head of such agency on such practices and policies.
(b) Report to Congress
Not later than four years after August 9, 2022, the Director of the National Science Foundation shall submit a report to Congress that includes a summary and analysis of the types and frequency of activities and policies developed and carried out under subsection (a) based on the reports submitted under paragraph (2) of such subsection.
(Pub. L. 117–167, div. B, title V, § 10505, Aug. 9, 2022, 136 Stat. 1612.)
42 U.S.C. § 19156 (THE PUBLIC HEALTH AND WELFARE)
§ 19156. Existing activities
A Federal research agency may satisfy requirements under this part through activities and programs in existence as of August 9, 2022.
(Pub. L. 117–167, div. B, title V, § 10506, Aug. 9, 2022, 136 Stat. 1612.)
42 U.S.C. § 19157 (THE PUBLIC HEALTH AND WELFARE)
§ 19157. Merit review
Nothing in this part may be construed as altering any intellectual or broader impacts criteria at Federal research agencies for evaluating award applications.
(Pub. L. 117–167, div. B, title V, § 10508, Aug. 9, 2022, 136 Stat. 1613.)
heading: Editorial Notes
heading: References in Text
text: This part, referred to in text, was in the original “this subtitle”, meaning subtitle A (§§ 10501–10510) of title V of div. B of Pub. L. 117–167, Aug. 9, 2022, 136 Stat. 1609, which is classified principally to this part. For complete classification of subtitle A to the Code, see Tables.